SA PRO
Free Account
Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 88% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
88%
Rating Distribution
Strong Buy
00%
Buy
1488%
Hold
00%
Sell
213%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 1, 2025Jefferies
Enanta upgraded to Buy from Hold at Jefferies
Target:$20.00
+83.7%from $10.88
Jun 3, 2025JMP Securities
Enanta price target raised to $24 from $23 at Citizens JMP
Target:$24.00
+233.8%from $7.19
Dec 9, 2022H.C. Wainwright
HC Wainwright & Co. Initiates Coverage On Enanta Pharmaceuticals with Buy Rating, Announces Price Target of $56
Target:$56.00
+33.5%from $41.96
Nov 22, 2022RBC Capital
RBC Capital Maintains Sector Perform on Enanta Pharmaceuticals, Lowers Price Target to $54
Target:$54.00
+16.4%from $46.40
Jul 29, 2022Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
Target:$87.00
+69.7%from $51.27

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance